Multiple linear regression analysis identified increasing the dose of metformin treatment as the only independent factor associated with decreased MDA-LDL ( coefficient 0.367 , P < 0.0119 ) , and no significant correlation between change in MDA-LDL and fasting blood glucose or HbA1c .